PRE-MARKET INDIAN STOCKS NEWS: Earnings from Hero MotoCorp, ICICI Prudential, Tata Elxsi

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

PRE-MARKET INDIAN STOCKS NEWS: Earnings from Hero MotoCorp, ICICI Prudential, Tata Elxsi

Japan sells JPY 1.9tln 5-year JGBs; b/c 3.56x (prev. 3.42x), average yield 2.379% (prev. 2.239%)

BHP (BHP AT) and Escondida mine supervisors' union resume talks to avert strike

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.

Adani Enterprises (ADE IS) - Co. signed a non-binding MoU with Jabil (JBL) to establish a 50:50 JV for manufacturing and assembling AI and data centre equipment in India. (Economic Times)

Bank of Baroda (BOB IS) - NMC Healthcare founder BR Shetty is seeking USD 15bln in damages from the Co. and 25 other defendants over alleged fraud linked to NMC Healthcare. (Moneycontrol)

Bharat Electronics (BHE IS) - Co. secured additional orders worth INR 5.33bln since 17th September 2026, covering communication equipment, avionics, cybersecurity solutions, drones, jammers, software, upgrades, spares and services. (Economic Times)

Hero MotoCorp (HMCL IS) - Co. Q1 FY27 (INR) net rose 115.3% Y/Y to 102mln, rev. rose 24.9% Y/Y to 3.19bln. (Moneycontrol)

Hindustan Oil Exploration (HOE IS) - Co. appointed Debabrata Das as CFO, effective 16th October. (Economic Times)

Hyundai Motor India (HYUN IS) - Hyundai Motor Group announced plans to invest USD 15.5bln in India between 2026 and 2032. (Economic Times)

ICICI Prudential Life Insurance (IPRU IS) - Co. Q2 net rose 25% Y/Y, supported by growth in new business and a shift towards protection and annuity products. (Economic Times)

SBI Funds Management - Co. appointed R S Srinivas Jain as joint CEO and key managerial personnel, effective 13th October. (Moneycontrol)

Tata Elxsi (TELX IS) - Co. Q2 (INR) net fell to 1.703bln (prev. 1.706bln Q/Q). (Economic Times)

Zydus Lifesciences (ZYDUSLIF IS) - Co.'s Moraiya manufacturing facility in Ahmedabad received five observations following a US FDA inspection conducted between 5th and 13th October. (Moneycontrol)

Context

This is the standard pre-market digest format rather than a single print, and the tape reaction to such roundups has historically been idiosyncratic, name by name, rather than index-level. The earnings items carry the usual caveats for the Indian reporting season: sequential comparisons matter more than year-ago optics for the IT services names, where margin trajectory and deal commentary have tended to drive the move more than the headline profit line, and for insurers the mix shift toward protection and annuity products is the variable the market prices rather than the absolute number. The non-earnings items split cleanly by type: MoUs of the JV variety are non-binding by construction and past episodes of this kind have faded unless followed by capital commitments and timelines, while order-book additions for defence electronics names are recurring disclosures that markets have tended to treat as incremental rather than re-rating. The FDA observation item is the one with established precedent risk: the count and classification of observations, and whether any escalation follows in subsequent correspondence, has historically separated transient hits from sustained multiple compression for Indian pharma exporters. Litigation claims of the size cited against the bank are typically long-tail events with distant resolution, and the initial reaction in comparable cases has tended to overstate the eventual provisioning.

Related headlines

The feed had this first.

Use the Platform